Repurchase of the Catheter Convertible Notes removes conversion overhang and supports QHSLab’s financial discipline and growth outlook. Company Reports Robust Q3 2025 Year-Over-Year Revenue Growth, Expanded Gross Profit, and Strengthened Operating Metrics West Palm Beach, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ), a medical device and digital health company enabling primary care... Read More

Back-to-School Season Just Got Smarter The Pediatric Health Assessment empowers parents and providers to uncover hidden health or behavioral issues that may affect academic and social success. QHSLab’s platform delivers critical insights at the perfect time for pediatricians to support whole-child wellness as families prepare for the new academic year. West Palm Beach, FL, Sept. 02, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the... Read More

Innovative initiative combines QHSLab’s digital platform with on-site behavioral health services to advance timely, effective care. MIAMI, FL, July 08, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ) , a digital health company advancing personalized medicine through innovative population health screening and point of care diagnostic tools in primary care, announced today the opening of its first co-branded... Read More

Recent publications highlight the efficacy of QHSLab's digital assessments in primary care, offering benefits for providers, patients, and practice revenue. WEST PALM BEACH, FL, June 03, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ) , a digital health company advancing personalized medicine through innovative population health screening and point of care diagnostic tools in primary care, announces the... Read More

Company in Advanced Discussions to Restructure Convertible Debt and Unlock Shareholder Value Potential Agreement Expected to Improve Financial Flexibility and Reduce Dilution Pressure WEST PALM BEACH, FL, May 16, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ) , a digital health company advancing personalized medicine through innovative population health screening and point of care diagnostic tools in... Read More

Revenue increased 32% year-over-year to $645,419, driven by growth in ISP and Allergy Diagnostics Gross margin expanded to 66.6%, reflecting improved product mix and operational efficiencies WEST PALM BEACH, FL, May 15, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ) , a digital health company advancing personalized medicine through innovative population health screening and point of care diagnostic tools... Read More

WEST PALM BEACH, FL, Feb. 26, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ) , a digital health company advancing personalized medicine through innovative population health screening and point of care diagnostic tools in primary care, today announced it has engaged Hayden IR, a highly recognized national investor relations firm, to raise its visibility and strengthen its relationships with the investment... Read More

Expanding market reach to drive organic revenue growth without equity dilution Collaborating with AI-driven health assessments and customized pharmacy solutions to enhance patient care. Integrating Digital Health & Compounded Medications to bridge the gap between digital screening tools and patient-specific pharmaceutical treatments. Bringing Scalable, Data-Driven Healthcare to 200+ Primary Care Practices WEST PALM BEACH,... Read More

NSF Recognition: A Testament to Innovation Driving Strategic Growth and Shareholder Value WEST PALM BEACH, FL, Dec. 13, 2024 (GLOBE NEWSWIRE) -- QHSLab Inc. ("the Company") (OTCQB: USAQ) , a leading provider of digital healthcare solutions and diagnostic technologies, is thrilled to announce that it has been invited by the prestigious National Science Foundation (NSF) to submit a full Phase I application for the development... Read More

Revenue Growth and APA Recognition Drive Momentum for QHSLab in 2024 WEST PALM BEACH, FL, Nov. 25, 2024 (GLOBE NEWSWIRE) -- QHSLab Inc. ("the Company") (OTCQB: USAQ) , an emerging leader in digital healthcare solutions and value-based clinical technologies, today proudly announces significant milestones that underscore its progress in 2024. These accomplishments demonstrate the Company’s commitment to advancing patient care,... Read More

Revenue Soars 62% Year-Over-Year in Q3 2024, with Gross Margin Expanding to 67.1% Integrated Service Program (ISP) Revenue Up 143% Year-to-Date, Marking Continued Demand for Digital Health Solutions Net Income of $49,765 for the Quarter Reflects Operational Efficiencies and Strategic Focus Strengthens Balance Sheet with Over $100,000 in Debt Repayments, Highlighting Commitment to Sustainability and Growth. Milestone... Read More

WEST PALM BEACH, FL, Oct. 22, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based healthcare solutions, is pleased to announce the addition of Dr. Juan D. Oms, a board-certified psychiatrist with extensive expertise in behavioral health and substance use disorders, as a medical advisor. Dr.... Read More

WEST PALM BEACH, FL, Sept. 25, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based healthcare solutions, is proud to announce a significant grant sponsorship from a Global Leader in Consumer Health. This $297,360 grant will fund a pivotal study titled “Harnessing Digital Medicine Tools for... Read More

WEST PALM BEACH, FL, Sept. 17, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based healthcare solutions, today shared exciting updates on its Research & Development (R&D) activities , and patient outcomes for the year to date. The Company continues advancing healthcare technology by... Read More

Significant Improvement in Profitability and Cash Flow Management WEST PALM BEACH, FL, Aug. 14, 2024 (GLOBE NEWSWIRE) -- QHSLab Inc. ("the Company") (OTCQB: USAQ) , a leader in digital healthcare and point-of-care technologies designed to empower clinicians with proactive value-based healthcare solutions, today announced detailed financial results for the second quarter and six months ended June 30, 2024. The Company’s... Read More

Integrated Service Program (ISP) Revenues Surge 268% in Q1 2024 Over Q1 2023 WEST PALM BEACH, FL, May 13, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. ("the Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based healthcare solutions, today released detailed financial results for the first quarter ended March 31, 2024, showcasing not only revenue... Read More

WEST PALM BEACH, FL, May 02, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based healthcare solutions, today announced the appointment of Dr. Marcos Sanchez-Gonzalez as the new Vice President of Medical and Scientific Affairs. Strategic Role and Objectives In his new role, Dr. Sanchez-Gonzalez... Read More

WEST PALM BEACH, FL, April 26, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. ("the Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based healthcare solutions, today announced its preliminary unaudited revenue for the first quarter ended March 31, 2024. Financial Highlights: ● First Quarter Revenues were $488,587, a 38% increase over the $352,799... Read More

WEST PALM BEACH, FL, March 28, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging digital health and point-of-care technologies, today reported its financial and operational results for the fiscal year ended December 31, 2023. The year was marked by robust revenue growth, significant... Read More

This integration allows QHSLab access to more than 160,000 providers that are the exact match for target providers. WEST PALM BEACH, FL, Jan. 30, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging digital health and point-of-care technologies, is proud to announce the seamless... Read More

25% Y-O-Y Revenue Growth in Q3 2023 Compared to Q3 2022 and 51% Increase in Gross Profit. ● In Q3 2023, QHSLab generated $336,407 in revenues, reflecting a notable 25% year-over-year increase from the $269,323 reported in Q3 2022. ● Achieved a 55% gross margin over the nine months ending September 30, 2023, representing a 551-basis point growth in gross profit compared to the same period in 2022, and realized a remarkable... Read More

WEST PALM BEACH, FL, Oct. 25, 2023 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging digital health and point-of-care technologies, is proud to announce that since the start of Q4 2023 it has gained six new multi-location customer accounts for its Integrated Service Program (ISP) in... Read More

WEST PALM BEACH, FL, Oct. 18, 2023 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging digital health and point-of-care technologies, is proud to announce a series of accomplishments year-to-date (YTD) demonstrating the company's commitment to transforming patient care through technology... Read More

324% Sequential Revenue Growth in Q1 2023 Compared to Q4 2022 for its Digital Medicine Services. ● Total Q1 2023 revenue of $352,799 increased 32% over Q4 2022 revenue ● Expanded gross margin in Q1 2023 to 53% resulting in a 300-basis point increase in gross profit compared to the Q4 2022 ● Digital Medicine Subscription and Services Recurring Revenue combined grew by 168% in Q1 2023 compared to Q4 2022 ● Shareholders are... Read More

WEST PALM BEACH, FL, Feb. 16, 2023 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging digital health and point-of-care technologies, announces entry into a representation agreement with Florida based, Healthcare Information Technology Specialists, LLC. QHSLab, Inc. (QHSLab) and Healthcare... Read More

QHSLab reports that commercialization and the path to profitability is in clear sight, which is an unfamiliar acknowledgment for investors focused on the digital health community, many of which are currently witnessing poor outcomes from their previous investments. Multiple digital health companies have shed millions without creating a revenue stream. QHSLab is an alternative for investors to refocus and recoup on these... Read More